58 Days
Source:
مرسال قطر
Source: مرسال قطر
58 Daysمرسال قطر
Source: مرسال قطر
58 DaysReady to play
Ready to play
Some individuals experience serious blood clots after using heparin, and this condition is associated with what is known as heparin-induced thrombocytopenia (HIT). HIT is a rare immune response that leads to the formation of dangerous blood clots despite the patient being on anticoagulant therapy. It typically occurs between 5 to 14 days after starting treatment and is characterized by symptoms such as pain and swelling in the affected areas, an increase in white blood cell count, and a decrease in platelet numbers. Early diagnosis and immediate treatment are crucial to reduce complications, usually involving the discontinuation of heparin and administration of alternative anticoagulants. Studies indicate that this condition can lead to serious complications like strokes and pulmonary embolisms, with an incidence estimated at approximately 0.1% to 5% among patients treated with heparin. Therefore, careful risk-benefit assessment is essential during heparin therapy.
Notice: This Is an AI-Generated Summary
Comments (0)